Expression of other genes, including PATZ1, MYC-3, and RUNX3, as well as microRNAs and non-coding RNAs, have also been assessed for their prognostic and diagnostic utility in DLBCL [48–51]. The gene discussed is PATZ1; the disease is diffuse large B-cell lymphoma.